08 Financial and Non-Financial Assets/Receivables

 (XLS:) Download XLS

 

€ million

 

2017

 

2016

 

 

Total

 

Of which noncurrent

 

Of which current

 

Total

 

Of which noncurrent

 

Of which current

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade receivables

 

655.7

 

 

655.7

 

775.7

 

 

775.7

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments

 

11.1

 

11.1

 

 

11.1

 

11.1

 

Loans granted

 

90.5

 

90.5

 

 

96.4

 

96.4

 

Receivables from associates

 

1.3

 

 

1.3

 

0.9

 

 

0.9

Loan and interest receivables

 

1.6

 

 

1.6

 

1.4

 

 

1.4

Derivative financial instruments

 

13.4

 

1.5

 

11.9

 

6.1

 

2.0

 

4.1

Insurance compensation

 

10.2

 

 

10.2

 

0.9

 

 

0.9

Receivables from suppliers

 

4.6

 

 

4.6

 

6.2

 

 

6.2

Deposits

 

3.1

 

2.5

 

0.6

 

2.9

 

1.4

 

1.5

Restricted cash and cash equivalents

 

0.2

 

 

0.2

 

0.4

 

 

0.4

Sundry assets

 

49.1

 

1.2

 

47.9

 

50.3

 

0.6

 

49.7

Other financial assets

 

185.1

 

106.8

 

78.3

 

176.6

 

111.5

 

65.1

 

 

 

 

 

 

 

 

 

 

 

 

 

Prepaid expenses

 

10.2

 

1.2

 

9.0

 

10.1

 

1.7

 

8.4

Plan assets for phased early retirement

 

0.3

 

 

0.3

 

0.4

 

 

0.4

Advance payments made

 

9.1

 

2.3

 

6.8

 

5.8

 

0.9

 

4.9

Other tax receivables

 

63.7

 

0.3

 

63.4

 

46.1

 

0.7

 

45.4

Sundry assets

 

6.5

 

 

6.5

 

8.5

 

0.4

 

8.1

Other non-financial assets

 

89.8

 

3.8

 

86.0

 

70.9

 

3.7

 

67.2

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax receivables

 

13.9

 

 

13.9

 

18.5

 

 

18.5

 

 

 

 

 

 

 

 

 

 

 

 

 

Insurance compensation in the amount of €10.2 million concerns insurance claims from the loss event at the Charleston production site. The purpose of this compensation is to restore the property, plant and equipment that was destroyed or damaged.

Receivables are shown at amortized cost, which corresponds to their market value. Adequate valuation allowances are set up to cover default risks, to the extent that these are not covered by insurance, bank guarantees or advance payments received.

Valuation allowances and past-due debts developed as follows:

 (XLS:) Download XLS
Changes in Valuation Allowances for Trade Receivables

 

 

 

 

 

€ million

 

2017

 

2016

 

 

 

 

 

 

 

 

 

 

As of Jan. 1

 

3.7

 

5.6

Utilization

 

 

-2.2

(+) Additions/(–) reversals

 

-0.1

 

0.2

Exchange-rate differences

 

-0.2

 

0.1

As of Dec. 31

 

3.4

 

3.7

 

 

 

 

 

 (XLS:) Download XLS
Changes in Past-Due Trade Receivables

 

 

 

 

 

€ million

 

2017

 

2016

 

 

 

 

 

 

 

 

 

 

Receivables that are neither past due nor written down

 

513.3

 

634.5

 

 

 

 

 

Receivables that are past due but not written down:

 

 

 

 

up to 30 days past due

 

120.6

 

134.0

31 to 45 days past due

 

10.2

 

3.3

over 45 days past due

 

11.4

 

3.5

Total

 

142.2

 

140.8

 

 

 

 

 

Written-down receivables

 

0.2

 

0.4

 

 

 

 

 

Carrying amount

 

655.7

 

775.7

 

 

 

 

 

No valuation allowances were recognized for other financial assets in either the period under review or the prior year. There was no significant credit risk as of December 31, 2017.

Valuation allowances are set up for identifiable credit risks and exchange-rate fluctuations. We continuously monitor the creditworthiness of our debtors to assess the intrinsic value of the corresponding receivables; where appropriate, we take out credit default insurance. In addition, customers make advance payments and provide bank guarantees. The maximum default risk is equal to the carrying amount of the uninsured receivables. No loans or receivables were renegotiated to prevent an overdue debt or possible valuation allowance. Based on past experience and on the conditions prevailing as of the reporting date, there are no restrictions with regard to credit quality. The additions and reversals in the valuation allowances for receivables in the reporting period mainly relate to Wacker Chemie AG.